Alzheimer's disease: Moving towards a vaccine.
Holtzman
David M
DM
D000544:Alzheimer Disease / Q000276:immunology* / Q000378:metabolism* / Q000503:physiopathology / Q000628:therapy; D016229:Amyloid beta-Peptides / Q000737:chemistry / Q000276:immunology / Q000378:metabolism; D000818:Animals; D000906:Antibodies / Q000276:immunology; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D018450:Disease Progression; D006801:Humans; D051379:Mice; D058225:Plaque, Amyloid / Q000276:immunology / Q000378:metabolism; D013997:Time Factors; D014612:Vaccines / Q000276:immunology* / Q000627:therapeutic use
D016229:Amyloid beta-Peptides; D000906:Antibodies; D014612:Vaccines